Employing the Help of the BHPI Molecule to Boost Anti-Cancer Drug Treatments

For decades, MCB and the University of Illinois have been at the forefront of understanding the role of estrogen and the estrogen receptor (ER) in causing breast cancer. This is essential work: Breast cancer is the most commonly diagnosed cancer in women, affecting roughly one in eight women in the...

Hitting the (Moving) Target of Drug Resistant Cancers

Benita Katzenellenbogen has delved into the causes and treatments for breast cancer and other hormone-dependent cancers for virtually her entire career. Her tireless work in the field has established her as a world-renowned expert.

Cholesterol byproduct hijacks immune cells, lets breast cancer spread

The study, reported in Nature Communications, identifies new potential drug targets that could inhibit the creation or actions of the dangerous cholesterol byproduct.

Professor David Shapiro Named Eugene Howe Scholar in Biochemistry

The Department of Biochemistry and the School of Molecular and Cellular Biology congratulate Professor David Shapiro, who has been named the Eugene Howe Scholar in Biochemistry.

Progress in Women's Reproductive Health and Fertility

Through the ages, fertility has played a central role in civilizations. Its cultural, socioeconomic, demographic, religious and global implications were and still are incalculable. A Wikipedia search for “fertility gods,” for example, yields a list of 35 cultures with one, and often...

Drs. Benita S. Katzenellenbogen and John A. Katzenellenbogen have been awarded the Fred Conrad Koch Lifetime Achievement Award by the Endocrine Society.

The Society’s highest honor, this annual award recognizes lifetime achievements and exceptional contributions to the field of endocrinology. Dr. Benita Katzenellenbogen is currently the Swanlund Chaired Professor of Molecular and Integrative Physiology, and Dr. John Katzenellenbogen is the Swanlund...

New drug stalls estrogen receptor-positive cancer cells and shrinks tumors

Biochemistry researchers in Dr. David Shapiro's lab, and a study team including researchers from the department of food science and human nutrition, the department of molecular and integrative physiology, the College of Medicine and the Cancer Center, have developed a new drug that kills estrogen...

New drug compounds show promise against endometriosis

An interdisciplinary research team, including molecular and integrative physiology professors Benita Katzenellenbogen and Milan Bagchi, has developed a new approach to treating endometriosis. Their research appears in Science Translational Medicine.

Scientists engineer human T cell receptors against cancer antigens

Graduate student Sheena Smith and Professor David Kranz of the Department of Biochemistry have developed an approach to discover T cell receptors that could be therapeutically useful against different cancers. In collaboration with graduate students Yuhang Wang and Javier Baylor and Professor Emad...

Scientists discover a new role for estrogen in the pathology of breast cancer

Biochemistry professor David Shapiro, M.D.-Ph.D student Neal Andruska, graduate student Xiaobin Zheng and their colleagues discovered a new mechanism by which estrogen contributes to the pathology of breast cancer. The findings are published in the journal Oncogene.